Recombinant Herpes Zoster Vaccine

BIOLOGICAL2 trials

Sponsors

Beijing Luzhu Biotechnology Co., Ltd., Changchun BCHT Biotechnology Co.

Conditions

HerpesHerpes ZosterVaccine-Preventable Diseases

Phase 1

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

Enrolling by invitationNCT07633197

Changchun BCHT Biotechnology Co.Herpes

Start: 2026-05-28End: 2027-11-30Target: 120Updated: 2026-06-08

Phase 3

A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

RecruitingNCT06088745

Beijing Luzhu Biotechnology Co., Ltd.Herpes Zoster, Vaccine-Preventable Diseases

Start: 2023-09-28End: 2026-12-31Target: 4Updated: 2023-10-18